startups digital health weight loss glp-1 Riding the Wegovy wave: The shifting focus to GLP-1s to tap the $150bn drug market These weight-loss startups tell customers
Description
References Moiz A, Filion KB, Tsoukas MA, Yu OH, Peters TM, Eisenberg MJ
Loss ~1215% weight loss Appetite suppressant Method Daily oral Avg
doi: 10.1001/jama.2015.9676 10 DaviesM
This impairment alone could contribute to the pathogenesis of diabetes
Cardiovascular outcomes and mortality after initiation of canagliflozin: analyses from the EASEL Study
Methods A web-based search was performed on 6 GLP-1 receptor agonists via the PubMed online database
